You are here: Industry Insights > Empagliflozin

News List

Proposal to Have Empagliflozin as Option for Children with Type 2 Diabetes SHEM OIRERE
April 19, 2023
Manufacturers of Jardiance, which contains the drug empagliflozin, which is used in the treatment of diabetes in adults, seeking approval in the US to make a version of the medicine to meet increasing demand from this group of young diabetes patients.
Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets expresspharma
January 08, 2021
They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets expresspharma
September 18, 2020
They are oral diabetes medicines that help control blood sugar levels.
Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults expresspharma
August 31, 2020
Boehringer Ingelheim announced the full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes.
Alembic Pharma gets tentative nod from USFDA for Empagliflozin and Linagliptin tablets expresspharma
August 28, 2020
Empagliflozin and Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin meets primary endpoint in Phase III heart failure trial expresspharma
July 31, 2020
It reduced the risk of cardiovascular death or hospitalisation for heart failure versus placebo on top of standards of care in adults with heart failure with reduced ejection fraction.
Lupin receives US FDA’s tentative approval for Empagliflozin and Linagliptin Tablets expresspharma
July 24, 2020
Empagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin Hydrochloride Tablets expresspharma
July 21, 2020
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of Boehringer lngelheim Pharmaceuticals.
Zydus gets tentative USFDA approval for empagliflozin and metformin hydrochloride tablets expresspharma
May 04, 2020
It will be manufactured at the group’s formulations manufacturing facility at SEZ in Ahmedabad.
Zydus receives tentative nod from USFDA for Empagliflozin Tablets expresspharma
April 13, 2020
The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.

Previous page 1 2 Next page